about
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaMajor reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic testsSafety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized TrialEffectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised TrialThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataComparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.The association between malaria parasitaemia, erythrocyte polymorphisms, malnutrition and anaemia in children less than 10 years in Senegal: a case control studyIdentifying malaria hotspots in Keur Soce health and demographic surveillance site in context of low transmission.Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trialSahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomesImproving malaria control in West Africa: interruption of transmission as a paradigm shift.Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalPotential Impact of Seasonal Malaria Chemoprevention on the Acquisition of Antibodies Against Glutamate-Rich Protein and Apical Membrane Antigen 1 in Children Living in Southern Senegal.Application of geographically-weighted regression analysis to assess risk factors for malaria hotspots in Keur Soce health and demographic surveillance site.Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in SenegalHaemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawalRandomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria.Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria settingA Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and AfricaParasitic Infections among Children under Five Years in Senegal: Prevalence and Effect on Anaemia and Nutritional Status.Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysisAcceptability by community health workers in Senegal of combining community case management of malaria and seasonal malaria chemoprevention.Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009Accuracy of HRP2 RDT (Malaria Antigen P.f®) compared to microscopy and PCR for malaria diagnosis in Senegal.Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.Standardised versus actual white cell counts in estimating thick film parasitaemia in African children under five.Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial.
P50
Q21034136-42F5CABA-EAAF-4632-8614-43791185B135Q28477670-D89CCE99-0DF5-40FE-9778-A569A88223EAQ28552803-03515C30-3FCF-4D38-A642-0F289B6D1EA2Q28553641-F7B60480-3268-4AF1-8EA4-A8CA05182664Q30936416-5E934338-A080-49D4-9B1F-F4D913073778Q33399342-3EFB6E18-5D38-4E9B-AEA6-389D388EB2D6Q33507089-F08299F6-A051-420B-A6A4-B71E308E7571Q33578910-0097BDA7-793C-4533-8FB6-4ED352DD42B5Q34443723-1BC09439-5A3B-4490-AFF5-75D834845FFDQ34610279-96056B7E-31E4-47BE-A878-C975E8D4FB9BQ35071899-8A6342DB-CB19-4BB5-8A9E-0F6754F3CE5CQ35189138-7DFCE8B4-EC5D-44B4-9AE0-EA8F7EC192D0Q35245962-4848BD8C-5522-4D6A-B72B-0D4E5433CCF9Q35643241-01ECD958-3E5D-4216-A0DD-A40E532F4CFBQ35777352-E4FEDFFD-1A38-4468-8872-CA5B7CCD0295Q35803237-FEE88BD7-CF3B-4EFE-98DE-BED1C8FBCFE3Q35803321-4218BF20-6B46-4212-85E1-6E935984C564Q35891353-90658091-82DA-43B4-B552-A76F8C6DAA9BQ36132032-4EAAB5D0-CA58-4A17-B989-0C73E1A73EF4Q36298558-B6DD5F13-E6CE-4772-8DD2-871C128D78C0Q36309115-F321987B-9722-4878-90FA-431F6CC7A942Q36398135-83A8073E-93F0-4D8C-9C4D-DBD59EBB6141Q36413462-C5939589-95D8-454C-855F-FD7E42DFCECFQ36450797-7FEED795-C24E-417B-B77A-6DB5415D529FQ36485077-29867CED-CEF1-4BF1-A88C-82CA5AFEDB36Q36561097-F8A696D4-6E7A-4BA1-AD6C-31ABEE1784C7Q36687437-45CB48D1-B7FB-4E77-A98C-D68BE5BA8A6CQ36715829-FA284EB5-9691-4A73-B5EF-8790ABC3902FQ36962016-D12266A7-C8B9-45CE-BE30-55AD5B6A7A3BQ37119559-06992038-E7C8-4B8B-AC66-1335185030ADQ37350167-CAD50856-5BBB-4E8A-8B17-4FC34430CA3EQ37485151-B2D72CA0-B178-4507-8F52-EE34EAE05AC0Q37703517-D1996933-FF9F-46BC-ABE6-E3E8EFB5B1E7Q37726451-25D22071-B232-4695-8C70-F86B29A5C45CQ37982355-B1638C9E-E393-4BC2-8D3C-05B3E1563DABQ38973256-6A4A5629-B754-4CC7-9480-1D8E28F24199Q39004073-E9746878-5603-4E55-9CDC-30B380371664Q39322791-2ACC5737-53E4-462A-9D78-97437680B7D6Q39525461-CE873AF6-C16E-4CAB-A02B-B77AD7924163Q39525467-9E3051E1-6003-4339-9236-C131E1186F77
P50
description
researcher ORCID ID = 0000-0003-0450-5551
@en
wetenschapper
@nl
name
Jean Louis Ndiaye
@ast
Jean Louis Ndiaye
@en
Jean Louis Ndiaye
@es
Jean Louis Ndiaye
@nl
type
label
Jean Louis Ndiaye
@ast
Jean Louis Ndiaye
@en
Jean Louis Ndiaye
@es
Jean Louis Ndiaye
@nl
prefLabel
Jean Louis Ndiaye
@ast
Jean Louis Ndiaye
@en
Jean Louis Ndiaye
@es
Jean Louis Ndiaye
@nl
P21
P31
P496
0000-0003-0450-5551